Literature DB >> 25453345

Risk factors differ between recurrent and incident preeclampsia: a hospital-based cohort study.

Nansi S Boghossian, Edwina Yeung, Pauline Mendola, Stefanie N Hinkle, S Katherine Laughon, Cuilin Zhang, Paul S Albert.   

Abstract

PURPOSE: To examine whether risk factors, including prepregnancy body mass index (BMI), differ between recurrent and incident preeclampsia.
METHODS: Data included electronic medical records of nulliparas (n = 26,613) delivering 2 times or more in Utah (2002-2010). Modified Poisson regression models were used to examine (1) adjusted relative risks (RR) of preeclampsia and 95% confidence intervals (CI) associated with prepregnancy BMI; (2) maternal risk factor differences between incident and recurrent preeclampsia among primiparous women.
RESULTS: In the first pregnancy, compared with normal weight women (BMI: 18.5-24.9), preeclampsia risks for overweight (BMI: 25-29.9), obese class I (BMI: 30-34.9), and obese class II/III (BMI: ≥ 35) women were 1.82 (95% CI = 1.60-2.06), 2.10 (95% CI = 1.76-2.50), and 2.84 (95% CI = 2.32-3.47), respectively, whereas second pregnancy-incident preeclampsia risks were 1.66 (95% CI = 1.27-2.16), 2.31 (95% CI = 1.67-3.20), and 4.29 (95% CI = 3.16-5.82), respectively. Recurrent preeclampsia risks associated with BMI were highest among obese class I women (RR = 1.60; 95% CI = 1.06-2.42) without increasing in a dose-response manner. Nonwhite women had higher recurrence risk than white women (RR = 1.70; 95% CI = 1.16-2.50), whereas second pregnancy-incident preeclampsia risk did not differ by race.
CONCLUSION: Prepregnancy BMI appeared to have stronger associations with risk of incident preeclampsia either in the first or second pregnancy, than with recurrence risk. Nonwhite women had higher recurrence risk.

Entities:  

Mesh:

Year:  2014        PMID: 25453345      PMCID: PMC4355246          DOI: 10.1016/j.annepidem.2014.10.003

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  33 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Recurrent preeclampsia: the effect of weight change between pregnancies.

Authors:  Dorothea Mostello; Jen Jen Chang; Judy Allen; Laura Luehr; Jaye Shyken; Terry Leet
Journal:  Obstet Gynecol       Date:  2010-09       Impact factor: 7.661

3.  Can we predict recurrence of pre-eclampsia or gestational hypertension?

Authors:  M A Brown; C Mackenzie; W Dunsmuir; L Roberts; K Ikin; J Matthews; G Mangos; G Davis
Journal:  BJOG       Date:  2007-06-14       Impact factor: 6.531

Review 4.  Maternal adiposity as an independent risk factor for pre-eclampsia: a meta-analysis of prospective cohort studies.

Authors:  Z Wang; P Wang; H Liu; X He; J Zhang; H Yan; D Xu; B Wang
Journal:  Obes Rev       Date:  2013-03-26       Impact factor: 9.213

5.  Differential risk of hypertensive disorders of pregnancy among Hispanic women.

Authors:  Myles Wolf; Anand Shah; Ricardo Jimenez-Kimble; Jenny Sauk; Jeffrey L Ecker; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

Review 6.  Obesity: a risk factor for preeclampsia.

Authors:  Scott W Walsh
Journal:  Trends Endocrinol Metab       Date:  2007-11-19       Impact factor: 12.015

7.  The NICHD Consecutive Pregnancies Study: recurrent preterm delivery by subtype.

Authors:  S Katherine Laughon; Paul S Albert; Kira Leishear; Pauline Mendola
Journal:  Am J Obstet Gynecol       Date:  2013-09-11       Impact factor: 8.661

8.  The risk of preeclampsia rises with increasing prepregnancy body mass index.

Authors:  Lisa M Bodnar; Roberta B Ness; Nina Markovic; James M Roberts
Journal:  Ann Epidemiol       Date:  2005-08       Impact factor: 3.797

9.  Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy.

Authors:  Lisa M Bodnar; Janet M Catov; Mark A Klebanoff; Roberta B Ness; James M Roberts
Journal:  Epidemiology       Date:  2007-03       Impact factor: 4.822

10.  Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies.

Authors:  Darios Getahun; Cande V Ananth; Yinka Oyelese; Martin R Chavez; Russell S Kirby; John C Smulian
Journal:  Obstet Gynecol       Date:  2007-12       Impact factor: 7.623

View more
  17 in total

1.  Risk Factors for Preeclampsia in a High-Risk Cohort of Women Served by a Nursing-based Home Visiting Program.

Authors:  Candace Tannis; Rachel Fletcher-Slater; Inessa Lopez; Alexandrah Gichingiri; Mario Cassara; Susanne Lachapelle; Elizabeth Garland
Journal:  Int Public Health J       Date:  2018-10-01

2.  Putting the "M" back in maternal-fetal medicine: A 5-year report card on a collaborative effort to address maternal morbidity and mortality in the United States.

Authors:  Mary E D'Alton; Alexander M Friedman; Peter S Bernstein; Haywood L Brown; William M Callaghan; Steven L Clark; William A Grobman; Sarah J Kilpatrick; Daniel F O'Keeffe; Douglas M Montgomery; Sindhu K Srinivas; George D Wendel; Katharine D Wenstrom; Michael R Foley
Journal:  Am J Obstet Gynecol       Date:  2019-03-05       Impact factor: 8.661

3.  Retinol-Binding Protein 4 and Lipids Prospectively Measured During Early to Mid-Pregnancy in Relation to Preeclampsia and Preterm Birth Risk.

Authors:  Pauline Mendola; Akhgar Ghassabian; James L Mills; Cuilin Zhang; Michael Y Tsai; Aiyi Liu; Edwina H Yeung
Journal:  Am J Hypertens       Date:  2017-06-01       Impact factor: 2.689

4.  Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology.

Authors:  Tamara Garrido-Gomez; Francisco Dominguez; Alicia Quiñonero; Patricia Diaz-Gimeno; Mirhan Kapidzic; Matthew Gormley; Katherine Ona; Pablo Padilla-Iserte; Michael McMaster; Olga Genbacev; Alfredo Perales; Susan J Fisher; Carlos Simón
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

5.  Chronic kidney disease in preeclamptic patients: not found unless searched for-Is a nephrology evaluation useful after an episode of preeclampsia?

Authors:  Zineb Filali Khattabi; Marilisa Biolcati; Antioco Fois; Antoine Chatrenet; Delphine Laroche; Rossella Attini; Marie Therese Cheve; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2019-07-17       Impact factor: 3.902

6.  Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia.

Authors:  Mary Catherine Tolcher; Derrick M Chu; Lisa M Hollier; Joan M Mastrobattista; Diana A Racusin; Susan M Ramin; Haleh Sangi-Haghpeykar; Kjersti M Aagaard
Journal:  Am J Obstet Gynecol       Date:  2017-04-25       Impact factor: 8.661

7.  Pre-eclampsia in American Indians/Alaska Natives and Whites: The Significance of Body Mass Index.

Authors:  Anna Zamora-Kapoor; Lonnie A Nelson; Dedra S Buchwald; Leslie R Walker; Beth A Mueller
Journal:  Matern Child Health J       Date:  2016-11

Review 8.  Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia.

Authors:  Christine Maric-Bilkan; Vikki M Abrahams; S Sonia Arteaga; Ghada Bourjeily; Kirk P Conrad; Janet M Catov; Maged M Costantine; Brian Cox; Vesna Garovic; Eric M George; Alison D Gernand; Arun Jeyabalan; S Ananth Karumanchi; Aaron D Laposky; Menachem Miodovnik; Megan Mitchell; Victoria L Pemberton; Uma M Reddy; Mark K Santillan; Eleni Tsigas; Kent L R Thornburg; Kenneth Ward; Leslie Myatt; James M Roberts
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

9.  Analysis of perinatal coagulation function in preeclampsia.

Authors:  Chang Xu; YunHui Li; Wen Zhang; QiuShi Wang
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

Review 10.  Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.

Authors:  Emily Bartsch; Karyn E Medcalf; Alison L Park; Joel G Ray
Journal:  BMJ       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.